Table 1. Demographics characteristics of the study population.
| Variables | death (n = 162) | control (n = 162) | p |
|---|---|---|---|
| Recipient age (years), mean ± SD | 50.3 ± 12.2 | 49.8 ± 12.6 | 0.971 |
| Recipient gender (male), N (%) | 96 (59.3) | 102 (63) | 0.494 |
| Cause of chronic kidney disease, N (%) | 0.418 | ||
| Undetermined | 75 (46.3) | 79 (48.8) | |
| Hypertension | 14 (8.6) | 11 (6.8) | |
| Diabetes mellitus | 32 (19.8) | 24 (14.8) | |
| Glomerulonephritis | 11 (6.8) | 17 (10.5) | |
| Time on dialysis (months), mean ± SD | 53.9 ± 41.5 | 36.9 ± 31.0 | < 0.001 |
| Type of renal replacement therapy, N (%) | 0.019 | ||
| Preemptive | 2 (1.2) | 12 (7.4) | |
| Hemodialysis | 146 (90.1) | 140 (86.4) | |
| Peritoneal | 14 (8.7) | 10 (6.2) | |
| History of diabetes mellitus, N (%) | 47 (29) | 30 (18.5) | 0.026 |
| Prior contact with tuberculosis, N (%) | 3 (1.9) | 0 (0) | 0.082 |
| Panel reactive antibodies, (%) | |||
| Class I, mean ± SD | 7 ± 17 | 8 ± 20 | 0,265 |
| Class II, mean ± SD | 6 ± 19 | 3 ± 13 | 0,01 |
| HLA mismatches, mean ± SD | 2.8 ± 1.6 | 2.3 ± 1.6 | 0.64 |
| Donor age, years, mean ± SD | 46.5 ± 12.7 | 46.0 ± 12.9 | 0.763 |
| Donor gender, male, N (%) | 79 (48.7) | 87 (53.7) | 0.405 |
| Donor type, N (%) | 0.968 | ||
| Living | 51 (31.5) | 53(32.7) | |
| Deceased Standard criteria | 76 (46.9) | 74 (45.7) | |
| Deceased Expanded Criteria | 35 (21.6) | 35 (21.6) | |
| Deceased donor cold ischemia time, hours, mean ± SD | 25.4 ± 6.42 | 24.9 ± 5.76 | 0.163 |
HLA: human leukocyte.